Follow up is a key stage in the lung cancer care pathway. 30 percent to 55 percent of patients with Non-Small Cell Lung Cancer (NSCLC) develop recurrence.10
10. Uramoto H, Tanaka F. Recurrence after surgery in patients with NSCLC. Transl Lung Cancer Res. 2014;3(4):242-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367696/#r3